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ROLE OF HYPOTHALAMIC NEUROPEPTIDE Y IN A GENETIC MODEL OF 
OBESITY - THE ZUCKER RAT. Katherine E. Martin and Streamson 
C. Chua, Jr. Rockefeller University, New York, NY. 
(Sponsored by John N. Forrest, Jr., Department of Medicine, 
Yale University School of Medicine) 
Human obesity is considered to have both behavioral and 
genetic components. The Zucker rat provides a valuable model 
of an inherited obesity syndrome caused by an unidentified 
autosomal recessive mutation of the fatty (fa) gene on 
chromosome 5. The development of obesity in animal models 
appears to be influenced by hypothalamic neuropeptide Y 
(NPY), via metabolic aberrations inducing hyperphagia, 
hyperinsulinemia, and energy conservation mechanisms. 
Elevated hypothalamic NPY levels have been demonstrated in 
obese adult Zucker rats. However, until recently, it has not 
been possible to assess the causal role of NPY in the 
development of this obesity, because the genotype of Zucker 
rat pups could not be determined prior to the onset of 
visible obesity. The creation of a new rat cross (13MxBN), 
similar to the Zucker rat strain (13M/13M), and 
identification of polymorphic genetic markers flanking the fa 
locus has permitted genotyping of 13MxBN rats at any age. 
The purpose of the present study was to elucidate the 
potential role of hypothalamic NPY in the development of the 
obese phenotype of the fatty rat, by comparing hypothalamic 
NPY levels in lean and preobese 13MxBN rat pups, using the 

RT-PCR and Northern blot methods. The RT-PCR technique, 
which requires amplification of target sequence, showed no 
statistically significant difference between 6-8 day-old lean 
and preobese pups. However, the Northern blot method, which 
detects native mRNA, demonstrated a significant elevation of 
-40%, (p<.021), in preobese rat pups at 7-8 days of age, 
compared to their lean littermates. Furthermore, the 
Northern blot results are consistent with those recently 
obtained with an RNAase protection assay. These studies 
provide evidence that elevated hypothalamic NPY is one of the 
earliest known molecular abnormalities in a genetic animal 
model of obesity, and suggest that NPY is integrally involved 
in producing the obese phenotype. 
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Genetics of Human Obesity: 
Human obesity is a common familial health disorder of 
developed countries that is associated with hypertension, 
non-insulin dependent diabetes mellitus (NIDDM), 
cardiovascular disease, and diminished longevity.42 Until 
recently, obesity was primarily attributed to gluttony, but 
accumulating evidence suggests that obesity is determined by 
genetic factors.6'8'21'41'42'53,54 Twin studies of body weight 
have shown that concordance rates for obesity in monozygotic 
twins are twice as high as those of dizygotic twins,53 
suggesting that genetic similarity plays a much stronger role 
in the development of obesity than familial environment. 
However, since most pairs of twins were raised in the same 
household, these studies were unable to sufficiently 
distinguish between the separate contributions of hereditary 
and environmental influences. Thus, adoption studies were 
performed which demonstrate that the weight of adult adoptees 
is far more closely correlated with that of their biological 
parents, than that of their adoptive parents. This finding 
further implicates genetic factors in the determination of an 
individual's weight.41,54 Another observation favoring the 
hereditary hypothesis is the striking prevalence of obesity 
in certain genetically homogenous and geographically isolated 
populations. The Native American Pima tribe of Arizona 
comprises one such population, in which more than 75% of its 
members are obese, and, interestingly, more than 45% have 
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NIDDM.42 The Pima tribe provides an unusual human model of 
genetic obesity and diabetes, which has been extensively 
studied.6'42 In addition, there are rare cases of human 
obesity that follow a clear pattern of Mendelian 
inheritance,21 and there are several genetic animal models of 
obesity thought to be the result of a single autosomal 
recessive mutation.11'21 The availability, for research 
purposes, of multiple genetically obese animal models further 
facilitates our understanding of the complex pathogenicity of 
human obesity. 
Metabolism of Obesity: 
Obesity is a disorder of fuel metabolism that cannot be 
exclusively attributed to hyperphagia . 36'28'43'44 Although 
extremely prevalent, obesity is not well understood because 
it is likely to be a mult i factorial disease.28'40'42'44 
Potential sites of deranged energy metabolism in the obese 
include adipose tissue, muscle tissue, and the 
hypothalamus.28'36'37 Of these, the hypothalamus is the 
highest center involved in the control of eating behavior,28 
and it is postulated that the hypothalamus actually 
determines a body weight "set point", such that any 
perturbations in weight will induce mechanisms designed to 
return the body to its original weight.33'40 Two hypothalamic 
neurotransmitters integrally involved in food intake and body 
metabolism include corticotropin releasing factor (CRF),lla 
and neuropeptide Y (NPY) .17'46'49-52 CRF inhibits feeding,113 
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while NPY is the most potent orexigenic (appetite 
stimulating) agent known.51 NPY is also known to stimulate 
release of the anabolic hormone insulin,39 and one of the 
primary endocrine derangements associated with obesity is 
insulin resistance.113'42 Many aspects of energy metabolism 
in obesity need further clarification, and one strategy is to 
investigate the neuroendocrine control of this function in a 
genetic model of obesity. 
Zucker Rat Model of Obesity and Exploration of 
Mechanisms: 
The obese Zucker rat provides a unique genetic model for 
the study of the development of obesity. This obese 
phenotype is produced by an autosomal recessive mutation of 
the fatty (fa) locus, which arose spontaneously in the Zucker 
(13M) rat strain.59 Although the specific gene has not yet 
been identified, the locus has been mapped to rat chromosome 
5, and is homologous to the mouse diabetes (db) mutation on 
chromosome 4.56 The obese Zucker syndrome is characterized by 
hyperphagia, hyperinsulinemia, insulin resistance, altered 
metabolism, hypothyroidism, and defective reproductive 
function.10 However, the exact mechanism(s) triggering the 
obese fatty phenotype have not yet been delineated. 
The Zucker obesity syndrome is characterized by the 
early onset of vastly increased fat storage, both in terms of 
adipocyte number and size.10 Direct measurements reveal 
increased deposition of white adipose tissue by the fifth day 
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of life,31 and the fa/fa rats are visibly obese by day 16, 
prior to the onset of hyperphagia at three weeks of age. 
Since hyperphagia does not manifest itself until after the 
obesity is evident, it clearly cannot be the causative factor 
of the obesity. In addition, it has been shown that fa/fa 
rats become obese even when their food intake is limited to, 
or less than that of their lean littermates,10 suggesting that 
the obese animals have an increased efficiency of fat 
storage.19 Of further note, the physical activity of lean and 
obese rats is similar, thus the weight gain of fa/fa rats 
cannot be attributed to reduced energy expenditure on 
activity.19 
A prominent phenotypic feature of the fatty rat, 
promoting obesity, is altered metabolism.10 By the second day 
of life, defective non-shivering thermogenesis is apparent in 
fa/fa rat pups, which impairs the ability of these animals to 
generate heat. Fuel that would otherwise be utilized in this 
metabolic process is deposited as adipose tissue, and is 
probably the most important source of energy for adipocyte 
storage in young fa/fa rat pups. However, when fa/fa pups 
are artificially reared slightly above the thermoneutral zone 
to circumvent their thermogenic defect, the fa/fa pups still 
deposit more fat than their lean littermates. Thus, 
defective thermoregulatory thermogenesis cannot be the 
primary cause of obesity in the Zucker rats.31 In another 
study, sympathetic stimulation of metabolism, with 
norepinephrine (NE), in fa/fa and lean rat pups was shown to 
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arrest the onset of obesity in the fa/fa pups until 16 days 
of age. After this age, despite continued NE administration, 
the preobese pups accumulated excess fat which could not be 
entirely accounted for by a decreased metabolic rate. This 
study demonstrates that defects in sympathetically controlled 
metabolism are not solely responsible for the development of 
obesity.35 
Any investigation into the triggering mechanism(s) of 
obesity in the Zucker fa/fa rat must focus on the peri-natal 
period because of the early onset of the obese phenotype, by 
day 5. This assumption precludes logical exploration of 
later developmental changes as precipitating causes of the 
obesity. For example, the alterations associated with the 
transition from suckling to independent, adult-like eating of 
solid food takes place about the twentieth day of age. 
Further, the transformation in the hormonal and metabolic 
milieu seen at puberty does not begin to take place until 
around day 60. None of the physiological changes associated 
with these later developmental milestones can be causally 
responsible for the obesity. To discover the cause, an 
appropriate area of investigation is the neuroendocrine 
regulation of eating behavior in fa/fa Zucker pups during the 
first week of life. 
Role of Neuropeptide Y in Obesity: 
Neuropeptide Y (NPY) , a 36 amino acid member of the 
pancreatic polypeptide family, was discovered to be a 
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neurotransmitter that dramatically stimulates feeding 
behavior.17 NPY is synthesized in the hypothalamic arcuate 
nucleus and the noradrenergic neurons of the brainstem which 
project to the hypothalamus. Injection of NPY 
intracerebroventricularly or directly into either the 
paraventricular nucleus (PVN) or ventromedial nucleus (VMN) 
of the hypothalamus stimulates feeding behavior, and 
decreases latency to feeding.17'51'52 Long-term 
intracerebroventricular (ICV) administration of NPY produces 
hyperphagia and eventually obesity.50 Furthermore, central 
administration of NPY triggers energy conservation mechanisms 
which decrease core temperature,30 lower heart and respiratory 
rates,26 and stimulate insulin release to promote energy 
storage.39 Food deprivation produces elevated hypothalamic 
NPY levels in mice, 15 and rats.4'9'29'46'48 There is, however, 
no change in brainstem levels of NPY with fasting,15 which 
indicates that alterations in NPY synthesis are site 
specific. These observations all suggest that hypothalamic 
NPY levels are integrally involved in the control of eating 
behavior. 
There is evidence that NPY plays a central role in the 
obesity syndrome of the fa/fa Zucker rat.3'29'48 It has been 
consistently demonstrated that obese adult Zucker rats have 
elevated hypothalamic NPY levels compared to their lean 
counterparts. Both NPY messenger ribonucleic acid (mRNA) and 
NPY peptide levels have been shown to be increased in adult 
fa/fa rats of various ages.3'29'48 Given that NPY is known to 
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stimulate eating behavior17'51'52 and energy conservation 
mechanisms,26'30'39 and that it is elevated in adult obese 
Zucker rats, it is likely that NPY is involved in the 
pathogenesis of obesity. The fatty gene, however, is not 
thought to be a mutation of the NPY locus, since the two 
genes are located on separate chromosomes. Furthermore, it 
is not clear if NPY is important in the early developmental 
expression of the obese phenotype in fa/fa rat pups. This 
research aims to resolve this intriguing question by 
comparing hypothalamic NPY levels in preobese and lean Zucker 
rat pups prior to the visible onset of obesity. 
Genotype Determination of Rat Pups : 
Until recently, it was difficult to determine the role 
of NPY in producing obesity in the fa/fa rat, because of the 
inability to easily and reliably distinguish preobese from 
lean pups prior to the visible expression of the obese 
phenotype. Several developments occurred which now allow 
early genotyping of rat pups. The obese Zucker phenotype 
which arose on the 13M strain background59 was introduced into 
a genetic cross between two strains: 13M and Brown Norway 
(BN), with fa co-segregating with the 13M allele. Mapping of 
the fa mutation,56 to rat chromosome 5, allowed the 
identification of two microsatellites flanking the fa locus, 
Glut-1 and c-Jun, 14 thereby permitting the creation of assays 
to genotype rats at a very early age. 

8 
Determination of NPY mRNA: 
For these studies it is preferable to detect NPY mRNA, 
rather than peptide levels, because mRNA is synthesized and 
stored in the neuronal cell bodies where it is produced. NPY 
peptides, however, are transported to synaptic vesicles which 
may be located in completely different areas than their 
corresponding cell bodies. In the hypothalamus, peptide 
levels partially represent synthesis in other areas, most 
notably the brainstem.15 Thus, NPY mRNA levels were assessed 
using both the traditional Northern Blot technique, described 
in detail elsewhere,15 and the newer Reverse Transcriptase - 
Polymerase Chain Reaction (RT-PCR) method. 
RT-PCR is based on the polymerase chain reaction, which 
is an extremely sensitive method for detecting a known 
deoxyribonucleic acid (DNA) sequence which may be present in 
very low copy number. There are three distinct stages of the 
polymerase chain reaction which occur at corresponding 
temperature plateaus: denaturation of complementary DNA 
template strands, annealing of primers to template, and 
synthesis of the opposing DNA strands. Two oligonucleotide 
primers are designed to anneal to the 5' ends of opposite 
strands of the template DNA sequence. A heat stable DNA 
polymerase, from Thermus aquaticus (Taq), is then used to 
synthesize the complementary DNA sequence between the two 
primers. In order to detect the presence of the DNA product, 
the entire reaction must be repeated many times (ie. usually 
20-35 times). In the first several cycles the desired DNA 
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product accumulates exponentially to a concentration of 10“ 
8m, then linearly, and finally reaches a concentration of 
approximately 10~7M at which little additional product is 
generated.5 The polymerase chain reaction is thus a method 
which greatly amplifies the amount of a specific DNA sequence 
relative to all other nucleic acid sequences in the original 
reaction mixture. 
Several modifications of the standard PCR must be made 
in order to quantitate NPY mRNA. Hypothalamic mRNA must 
first be reverse transcribed into complementary DNA (cDNA) 
because Taq DNA polymerase cannot use RNA as a template. 
Also the number of PCR cycles must be designed such that the 
product is still accumulating in an exponential manner; if 
the PCR continues cycling until the product concentration 
reaches the plateau region then any difference in original 
template cDNA amounts will be masked. In addition, to 
account for variations in the total amount of cDNA placed 
into the PCR, an actin product is used as an internal 
control. Since hypothalamic and brain stem levels of actin 
mRNA are known not to vary with fasting manipulations, actin 
should represent a constant fraction of total hypothalamic 
mRNA.15 Thus, within a given hypothalamic sample the NPY 
level is normalized to the corresponding actin level, 
permitting comparison of the relative amounts of NPY in 
different samples. As with many other techniques, the RT-PCR 
method results in a relative quantification of NPY mRNA, 
rather than an absolute measure. 

Materials and Methods 
Animals: 
All Zucker (13M/13M) rats were bred in a colony 
maintained at Vassar College. The FI (fa/+) adult animals 
were derived from matings between obese (fa/fa) 13M males and 
lean (+/+) Brown-Norway (BN) females. The rat pups used in 
these experiments were derived from matings of FI animals. 
All FI and F2 rats were housed in the Lab Animal Resource 
Center (LARC) at Rockefeller University in plastic cages with 
corn cob bedding and kept on a 12 hour light/12 hour dark 
cycle with lights on at 06:30 Eastern Standard Time. All 
subjects were maintained on Purina rat chow and water ad 
libitum except as noted in text. 
Rats were placed in a carbon dioxide-enriched atmosphere 
prior to decapitation, and organs were harvested immediately 
thereafter. The hypothalami were dissected as described by 
Glowinski and Iversen. Tissues were either immediately 
homogenized for RNA isolation, or frozen in liquid nitrogen 
and stored at -70°C. 
RNA Purification: 
Hypothalamic tissue was homogenized in 1 milliliter (ml) 
of GEM [7M guanidine hydrochloride (HC1), 25 millimolar (mM) 
EDTA, and 1% 2-mercaptoethanol (2-ME)]. The homogenate was 
extracted with 1/2 volume of a phenol and chloroform mixture 
(1:1), and the aqueous supernatant carefully aspirated. The 

RNA was precipitated by the addition of 1/20 volume of 3M 
sodium acetate (pH 4.5), and 1/2 volume of ethanol. After 
freezing, the solution was thawed and the precipitated RNA 
was further purified by washing with 0.1 ml of 3M sodium 
acetate and 1% 2-ME, and then ethanol. The RNA pellet was 
dissolved in water with 1% 2-ME. Total RNA yield was 
quantified from the optical density (OD) at 260 nanometers 
(nm), assuming 1 OD=33 micrograms (meg)/ml of RNA. 
RT-PCR: 
1 meg of RNA was reverse transcribed in 20 mcl of 0.05 M 
Tris-HCl (pH 8.3), 0.075 M potassium chloride (KC1), 3 mM 
magnesium chloride (MgCl2), 0.5 mM deoxynucleoside 
triphosphates (dNTP's), 10 mM Dithiothreitol (DTT) , 100 ng 
oligo(dT)i8, and 200 units of M-MLV-reverse transcriptase. 
The reverse transcription occurred at 37° C for 30-60 mins. 
The reaction mixture was then diluted with 80 mcl of water 
prior to heat-inactivation of the reverse transcriptase and 
dissociation of RNA/DNA hybrids at 100° C for 5 mins. The 
PCR was performed using the primers actin 1 and actin 3, 
yielding a 378 base pair (bp) product corresponding to codons 
235 to 360 of rat beta-actin, and the NPY primers alpha-CPON 
and NPY 61, producing a 225 bp product correlating to codons 
-28 to 47 of rat NPY (See Table 1) . Two mcl of cDNA were 
added to 20 mcl of 50 mM KC1, 10 mM Tris-HCl (pH 9.0), 0.1% 
Triton X-100, 0.2 mM dNTP's, 2.5 mM MgCl2, 0.2 mM spermidine, 
250 ng/100 mcl each of the actin and NPY primers, 5 U/100 mcl 
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Taq polymerase, 0.25-0.5 mcl of 3 5 S - d e o >: y adenosine 
triphosphate (dATP), specific activity (1000 Ci/mmol and 
lOmcCi/mcl), and water up to a final volume of 22 mcl. To 
produce cleaner PCR products the reaction was "hot-started" 
by separating equal amounts of buffer, MgCl2, dNTP's, and 
spermidine into two separate tubes. The DNA template, 
primers, and radioisotope were placed into one tube, and the 
Taq DNA polymerase into the other tube. The primer tube was 
layered with paraffin oil and heated to 94°C for one minute, 
and then the Taq mixture was added. Twenty PCR cycles were 
run at 94° C to denature, 65° C to anneal, and 72° C to extend 
for 30 seconds at each step in the Perkin Elmer thermal 
cycler, or for 60 seconds at each step in the MJ Research 
thermal cycler. The PCR products were size fractionated by 
electrophoresis on 5% polyacrylamide (PA) gels, and the dried 
gels were exposed to Kodak XAR film. Levels of mRNA were 
measured on the autoradiogram by densitometry using an LKB 
Ultroscan XL laser densitometer. For each sample, mRNA 
levels were expressed as the ratio of NPY/Actin to control 
for differences in loading, transfer, and RNA integrity. 
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Table 1: DNA sequences of oligonucleotide primers 
used in a PCR of an actin and NPY product 
Primer name DNA sequence 
actin 1 5' CTG GAG AAG AGC TAT GAG CTG CCT 
actin 3 5' CTC CTG CTT GCT GAT CCA CAT CTG 
alpha-CPON 
(NPY) 
5' TGA AAT CAG TGT CTC AGG GCT GGA 
NPY 61 5' ATG CTA GGT AAC AAG CGA ATG GGG 
The primers actin 1 and actin 3 yield a 378 bp product 
corresponding to codons 235 to 360 of rat beta-actin. The 
NPY primers alpha-CPON and NPY 61 produce a 225 bp product 
correlating to codons -28 to 47 of rat NPY. 
Northern Blot: 
Prior to electrophoresis, hypothalamic mRNA was 
denatured in an equal volume of RNA loading dye (50% 
formamide, 20% formaldehyde, 1% 2-ME, 1 mcg/ml of ethidium 
bromide (Et-Br) , 40 mM MOPS (pH 7), 20 mM sodium acetate, 1 
mM EDTA, 20% glycerol, and 0.01 % Bromophenol blue) by 
heating at 65° C for 10 minutes. Size fractionation was 
achieved by electrophoresis through 1.5% agarose gels in MAE 
(40mM MOPS, 20 mM sodium Acetate, 1 mM EDTA), containing 8% 
formaldehyde, 1 mcg/ml of Et-Br, and 0.1% 2-ME. The running 
buffer was MAE with 0.1 mcg/ml of Et-Br and 0.01% 2-ME. The 
RNA was transferred by capillary blotting to nitrocellulose 




The RNA was fixed by baking at 65° C for 2 hours 
under vacuum. 
Both NPY and actin radioactive probes were generated. 
The NPY plasmid pBL-NPY was digested with Eco RI to excise 
the insert.27 The actin probe is a PCR product corresponding 
to codons 235 to 360 of rat beta-actin. Total rat brain mRNA 
was reverse transcribed into cDNA and the product was 
amplified using the primers actin 1 and actin 3, previously 
described in the RT-PCR section. Both the NPY insert and 
actin fragment were electrophoresed on 1% agarose gels and 
purified on diatoms.7 The fragments were radiolabeled with 
32P-deoxycytosine triphosphate (dCTP) using the random primer 
labeling method.20 
Blots were wet in water and pre-hybr idi zed (50% 
formamide, 5X SSC, 5X Denhardt's, 0.1 mg/ml Herring sperm 
DNA, 0.1% SDS, and 5% polyethylene glycol [PEG]) at 37° C for 
1 to 2 hours. Hybridization with either the NPY or actin 
probe was performed in pre-hybridization solution at 37° C 
overnight. The blots were washed three times in 2X SSC with 
0.1% SDS at 65° C. The blots were exposed to Kodak XAR film 
at -70° C. Stripping of hybridized probes was done by 
washing the blots twice in 50% formamide with 0.IX SSC at 65° 
C. Levels of mRNA were measured by densitometry as described 





Rat tail, toe clips, spleens and other tissues were 
digested overnight at 65° in at least 20 volumes of 250 
mcg/ml proteinase K, 10 mM Tris, 10 mM EDTA, and 1% SDS. The 
tissue digest was extracted with 1/2 volume of a phenol and 
chloroform mixture (1:1) and the aqueous supernatant was 
carefully aspirated. The DNA was precipitated with 1/3 
volume of 10 M ammonium acetate and 2/3 volume of 
isopropanol. The DNA pellet was washed with ethanol and 
dissolved in 20mM Tris and 0.5 mM EDTA, pH 8. 
PCR Genotyping: 
DNA genotyping was performed by a PCR using rat rGlut-1 
and C-Jun primers. Glut-1 primers 1 and 2(See Table 2) were 
used in a PCR mixture as previously described in the RT-PCR 
section, except no radioactive isotope was used. 35 PCR 
cycles were run at 94° C to denature, 68° C to anneal, and 72° 
C to extend. The PCR products were electrophoresed on 8% PA 
gels and visualized under ultraviolet (UV) illumination after 
Et-Br staining. There is a product size difference of 
approximately 15-20 base pairs between BN and 13M, with the 
13M allele being larger than the BN allele 
For rat C-Jun, primers 1 and 2 were initially used which 
produce a -140 bp product,14 and later rC-Jun 5 and 6 were 
used which yield a smaller (-120 bp) and somewhat cleaner 
product. (See Table 2). There is a product size difference 
of 2 bases between BN and 13M, with the 13M allele being 
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larger than the BN allele. The C-Jun reaction was also 
performed according to the protocol in the RT-PCR section 
except that the 35S-dATP concentration varied from 0.1-0.25 
mcl/tube. 35 PCR cycles were run at 94, 60, and 72 degrees 
Celcius. The rC-Jun PCR products were analyzed either as 
single-stranded DNA (ssDNA) on denaturing PA gels, or as 
double-stranded DNA (dsDNA) on non-denaturing PA gels. Dried 
gels were exposed to Kodak XAR film. Each gel had DNA from 
animals of known genotype [{fa/fa), (fa/+), and (+/+)] which 
served as reference controls. 

Table 2: DNA sequences of Glut-1 and C-Jun 
oligonucleotide primers used in PCR genotyping of the fa 
locus 
Primer name DNA sequence 
primer 1 (Glut-1) 5 ' GAA TGA AGC TAA GAA TTG ACC TTA 
GGT 
primer 2 (Glut-1) 5' GTC CAT GCC TGT CCT TTA GTG CTC 
TTG 
C-Jun 1 5' GGG GTG CGG AGC CAG CTT CA 
C-Jun 2 5' CGG AGG GCT TGG GTG GGA G 
C-Jun 5 5' GCT TGG GTG GGA GTA GAG GT 
C-Jun 6 5' TTC AAT CGC CCA GAT CAT TCA 
rC-Jun primers 1 and 2 produce a 141 bp product.14 rC-Jun 5 and 
6 were yield a smaller 121 bp and somewhat cleaner product. There 
is a product size difference of 2 bases between BN and 13M, with 
the 13M allele being larger than the BN allele. 
Statistical Analysis: 
Non-parametric statistical analysis was performed 
because the small sample sizes (ie. average litter size 10, 
with only 25% fa/fa animals) of these experiments precluded 
the assumption of a normal distribution of hypothalamic NPY 
levels. Therefore medians rather than means were used, and 
all tests of statistical significance were performed using 
either the Mann-Whitney U test or Wilcoxon Rank sums test for 




All procedures were performed by this author, except 
those subsequently specified. Zucker rats were bred in a 
colony maintained at Vassar College. FI animals were bred 
under the supervision of Streamson Chua at Rockefeller 
University, and F2 animals were bred under the supervision of 
the author and Streamson Chua. Rats were housed and cared 
for by the LARC at Rockefeller University. Rats were 
sacrificed and organs dissected by the author, Streamson 
Chua, and David Markel at Rockefeller University. 
Oligonucleotide primers actin 1, actin 3, NPY alpha-CPON, NPY 
61, Glut-1 primers 1 and 2, and C-Jun primers 1,2,5 and 6 
were designed by Streamson Chua, and made by the Protein 
Sequencing Facility at Rockefeller University. The Northern 
blot assay performed on the six-week-old Zucker rats was done 
by Streamson Chua. The RT-PCR assay performed on this group 
of animals was done by the author. mRNA gel fractionation 
for the Northern blot assay performed on the 7-8 day-old F2 
BNxl3M rat pups was done by the author and Streamson Chua. 
Loraine Keogh, at Rockefeller University, assisted the author 
in radiolabeling the NPY and actin probes for the Northern 
blot. Splenic DNA isolation from the group of 7-8 day old 
rat pups was performed by David Markel, as was the C-Jun 
genotyping for these animals. All other DNA isolation, C- 
Jun, and Glut-1 genotyping was performed by the author. 
Statistical analysis using the Mann-Whitney U test was 
performed with the assistance of Rudolph Leibel at 
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Rockefeller University. The non-bar format graphs were 
generated at the Media Resources Center at Rockefeller 
University. 
Results 
Validation of RT-PCR Method: 
Elevations in rodent NPY mRNA due to food deprivation 
have been demonstrated by previous investigators, using 
several different methods including: Northern blot,29 
RIA,4'46 RNase protection assay,48 and in situ hybridization.9 
This robust phenomenon should therefore be reproducible and 
detectable by any method used. Thus, to evaluate the 
accuracy of the relatively new RT-PCR method, it was compared 
to prior results obtained using a standard Northern blot 
method. Six-week-old male Zucker rats were separated into 
groups of 4 animals each according to genotype [(+/+) vs. 
(fa/fa)], and feeding status [ad libitum fed vs. 24-hour 
fast]. The rats were sacrificed, the 4 hypothalami of each 
group pooled, and total RNA was isolated according to the 
protocol discussed in the Materials and Methods section. A 
Northern blot of NPY only, (actin levels were not 
determined), was performed and analyzed visually, which 
showed a striking increase in the NPY signal in both fasted 
groups. (See Figure 1). Note that there is an increase in 
the NPY message size range (< 100 bp) in the fasted groups, 
in addition to the increase in amount of NPY. This 
difference in NPY mRNA length may be secondary to variable 
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poly-adenylation of mRNA, which has been documented to occur 
in rat hypothalamic oxytocin and vasopressin mRNA when 
expression of the genes is stimulated by dehydration.12'57 
Figure 1: Northern blot determination of 
hypothalamic NPY mRNA Levels in 6-Week-Old 
Adult Lean and Obese Zucker Rats: Elevation in 
Fasted and Obese Groups* 
1 2 3 4 5 6 
* Zucker rats were separated into groups of 4 animals each 
according to genotype [(+/+) vs. (fa/fa)}, and feeding status {ad 
libitum fed vs. 24-hour fast vs. refed after a 24-hour fast]. The 
rats were sacrificed and the 4 hypothalami of each group pooled. 
Northern blot results are shown here. Lanes are shown in the 
following order from left to right: 1)lean fed group, 2)lean fasted 
group, 3)lean refed group, 4)obese fed group, 5)obese fasted 
group, and 6)obese refed group. Visual analysis shows a striking 
increase in NPY in the fasted groups. Note that there is an 
increase in the NPY message size range (< 100 bp) in the fasted 
groups, in addition to the increase in amount of NPY. This 
difference in NPY mRNA length may be secondary to variable 
poly-adenylation of mRNA. 
RT-PCR for both actin and NPY was performed on these 
same hypothalamic RNA samples according to the protocol in 
the Materials and Methods section. Triplicates were 
performed on each sample, which reveal a statistically 
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significant, (p <.05), -120% elevation of NPY in the fasted 
groups when compared to the corresponding ad libitum fed 
groups. (See Table 3 and Figure 2). Note that there is also 
an approximate 70% increase in the NPY values of the obese as 
compared to the lean groups, which was significant in the 
fasted group, (p <.05), and bordered on statistical 
significance in the fed group, (p =.05). These RT-PCR values 
appear to correlate with the results obtained from the 
Northern blot, suggesting that the RT-PCR method is able to 
detect significant differences in NPY mRNA expression. 
Further, this experiment shows that the RT-PCR method can 
reproduce results which are expected from previous studies 
using other techniques.2,3'47'48 
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Table 3: Hypothalamic NPY mRNA levels of 6-week-old 
adult lean and obese Zucker rats: elevation in fasted 
and obese groups 
* NPY mRNA levels normalized to actin mRNA of the same sample. 
NPY/Actin levels normalized to median of the lean fed group. 
Zucker rats were separated into groups of 4 animals each 
according to genotype [(+/+) vs. (fa/fa)], and feeding status 
[ad libitum fed vs. 24-hour fast] . The rats were sacrificed 
and the 4 hypothalami of each group pooled. Results reveal a 
statistically significant, (p <.05), -120% elevation of NPY 
mRNA in the fasted groups when compared to the corresponding ad 
libitum fed groups. Note that there is also an approximate 70% 
increase of NPY in the obese as compared to the lean groups, 
which was significant in the fasted group, (p < . 0 5) , and 
bordered on statistical significance in the fed group, (p 
= .05) . 

Figure 2: Hypothalamic NPY mRNA Levels in 6- 
Week-Old Adult Lean and Obese Zucker Rats: 














* Zucker rats were separated into groups of 4 animals each 
according to genotype [(+/+) vs. (fa/fa)], and feeding status {ad 
libitum fed vs. 24-hour fast]. The rats were sacrificed and the 4 
hypothalami of each group pooled. Triplicate RT-PCR assays 
were performed on each pooled sample. NPY mRNA levels were 
normalized to actin mRNA of the same sample. NPY/actin levels 
were expressed by normalization to the median of the lean fed 
group. Triplicates are shown with bars representing medians of 
the triplicates. Results reveal a statistically significant, 
(p<.05), ~120% elevation of NPY mRNA in the fasted groups 
when compared to the corresponding ad libitum fed groups. Note 
that there is also an approximate 70% increase of NPY in the 
obese as compared to the lean groups, which was significant in 
the fasted group, (p<.05), and bordered on statistical 
significance in the fed group, (p=.05). 
Adult Obese 13MxBN F2 Rats Also Have Higher 
Levels : 
NPY 
Several investigators, using various techniques, have 
shown increased hypothalamic NPY mRNA and peptide expression 
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in adult obese Zucker rats when compared to their lean 
counterparts.3/29,47 However, no analysis of NPY levels has 
been performed on adult F2 rats from the 13MxBN cross which 
segregates the recessive obese phenotype with the 13M 
alleles. The RT-PCR method which was shown to detect NPY 
elevations in obese Zucker rats, was employed on a group of 
11-week-old 13MxBN F2 rats to determine whether NPY levels 
are also increased in the obese animals of this cross. Three 
obese (fa/fa) and three lean controls were identified by 
gross phenotype, using the body mass index (BMI) which 
provides a measure of fatness which is independent of length. 
(See Table 4 and Figures 3, 4, and 5). PCR genotyping was 
not performed since genotyping is less accurate than 




Weight (g) ! Length (cm) j BMI 
Lean F 177.2 
t 
19.2 .481 
Lean F 206.7 ! 19.7 | .533 
Lean_ M 
: 
_281.1 21.5_| . 608 
Table 4: Sex, weight, length, and BMI* of lean 
and obese 11-wk-old 13MxBN F2 Rats 
Obese 
Obese 
BMI = wt/(length)2 
Statistical comparison between lean and obese animals 











Figure 3: Weight of Lean and Obese 
11-Week-Old Adult 13Mx BN Rats: 
Elevation in the Obese Group* 
Lean Obese 
Rat Phenotype 
* Rats were separated into 2 groups by gross 
phenotype. Weight was measured to the 
nearest 0.1 gram. Means are shown, with 
standard error bars. The weight of the obese 
group is statistically significantly higher, 
one-tailed probability using the Student's 
Unpaired t-Test, (p=.0443). 
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Figure 4: Length of Lean and 
Obese 11-Week-Old Adult 13MxBN 





* Rats were separated into 2 groups by 
gross phenotype. Length was measured to 
the nearest 0.1 cm. Means are shown with 
standard error bars. Results show no 
statistically significant difference between 




Figure 5: BMI of Lean and Obese 11- 
Week-Old Adult 13MxBN F2 Rats: 




* Rats were separated into 2 groups by gross 
phenotype. The BMI is equal to the weight 
divided by the length squared. Means are 
shown, with standard error bars. The weight 
of the obese group is statistically 
significantly higher, one-tailed probability 
using the Student's Unpaired t-Test, (p<.01). 
Total hypothalamic mRNA was isolated, reverse 
transcribed, and the PCR performed using both NPY and actin 
primers as outlined in the Materials and Methods section. 
Triplicates were performed on each hypothalamic sample. The 
medians of the NPY/actin triplicates, 1.00 for the lean group 
and 1.51 for the obese group, show that there is a 
statistically significant, (p <.05), elevation in NPY 
expression of approximately 50% in the obese animals. (See 
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Table 5 and Figure 6) . Note that a previous study of 11- 
week-old Zucker rats, using the Northern blot technique, did 
not demonstrate any difference between lean and obese 
animals,29 whereas this experiment detected a significant, 
though not large, increase in the F2 obese group. This 
discrepancy might be accounted for by the two different 
genotypic background strains used. This experiment shows 
that the RT-PCR method i s capable o f detecting smal 1 
elevations of NPY mRNA, similar to those found in obese 
Zucker rats, in adult obese 13MxBN F2 rats when compared to 
lean rats of the same age. 

Table 5: Hypothalamic NPY mRNA levels 
of lean and obese 11-wk-old adult 13MxBN 



























* NPY mRNA levels normalized to actin mRNA of 
the same sample. NPY/Actin levels normalized 
to median of lean group. 
Three obese (fa/fa) and three lean adult F2 
13MxBN rats were identified by gross phenotype. 
The medians of the NPY/actin triplicates, 1.00 
for the lean group and 1.51 for the obese 
group, show that there is a statistically 
significant, p<.05, elevation in NPY expression 
of approximately 50% in the obese animals. 

Figure 6: Triplicate Hypothalamic NPY mRNA Levels 
in 11-Week-Old Adult Lean and Obese 13MxBN F2 










* 3 obese {fa/fa) and 3 lean adult F2 13MxBN rats were 
separated into 2 groups by gross phenotype. Triplicate 
hypothalamic NPY mRNA determinations were performed on each 
sample using the RT-PCR method. NPY mRNA levels were 
expressed by normalization to the median of the lean group. 
Triplicates are shown with bars representing medians of the 
triplicates. Results reveal a statistically significant, (p<.05), 
-50% elevation of NPY mRNA in the obese group. 
Rat Pup Genotyping Issues: 
Rat pups were genotyped by two PCR based assays 
utilizing the rat chromosome 5 simple sequence repeat (SSR) 
polymorphisms for Glut-1 and C-Jun. The distance of Glut-1 
from the fa locus is 8.5 cent imorgans (cM) , and the 
corresponding distance from C-Jun to fa is 4.5 cM. The 
results of the two assays were not always in accord, which is 
possible if recombination occurs between the markers. All 
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possible genotype combinations are shown in Table 6, and 
whether a particular combination was included in further 
statistical analysis. Pups that scored 13M//13M by only one 
assay were not used in the analysis since the phenotype at 
the fa locus could not be unambiguously determined. Note 
that a 13M/13M genotyping result in both assays is 
considerably more accurate than a single assay 13M/13M 
determination, since the microsatellites are located on 
opposite sides of the fa locus. Using both assays in 
conjunction results in a 1 in 66 chance of erroneously 
calling a fa/fa pup a lean animal, while using only Glut-1 
gives a 1 in 6 chance, and using C-Jun alone gives a 1 in 11 
chance. A more detailed discussion of possible errors in 
assigning genotype at the fatty locus is given in Chua et. 
al., 1993.14 

Table 6: Possible genotype & phenotype results for 
F2 rat pups of the 13MxBN cross using rat chromosome 
5 Single Sequence Repeat (SSR) polymorphisms for 
Glut-1 and C-Jun in PCR linkage assays to the fa 
locus t 
t Rat pup genotyping is performed by PCR's in which 2 mcl of 
cDNA is added to 20 mcl of 50 mM KC1, 10 mM Tris-HCl (pH 
9.0), 0.1% Triton X-100, 0.2 mM dNTP's, 2.5 mM MgCl2, 0.2 mM 
spermidine, 5 U/100 mcl Taq polymerase, 250 ng/100 mcl each 
of either the Glut-1 or C-Jun primers, 0.1-0.25 mcl of 350_ 
dATP for the C-Jun reaction only, and water up to a final 
volume of 22 mcl. 35 PCR cycles are run at temperature 
plateaus of 94, 68, and 72° C for Glut-1, and 94, 60, and 72° 
C for C-Jun. Glut-1 PCR products are electrophoresed on 8% 
PA gels and visualized under UV illumination after Et-Br 
staining. rC-Jun PCR products are analyzed either as ssDNA 
on denaturing PA gels, or as dsDNA on non-denaturing PA gels. 
Dried gels are exposed to Kodak XAR film. 
BN = + allele 
13M = fa allele 
* Rat pups which are 13M/13M by only one assay are not 
included in further statistical analysis. 
Using both the Glut-1 and C-Jun assays in conjunction results 
in a 1 in 66 chance of erroneously calling a fa/fa pup a lean 
animal. 

RT-PCR Determination of Hypothalamic NPY Levels in 
13MxBN F2 Rat Pups: 
The RT-PCR assay was employed on young 13MxBN F2 rat 
pups to determine if hypothalamic NPY levels differ between 
preobese pups and their lean littermates. Three litters of 
rat pups were toe clipped on the second to third day of life 
for genotype analysis. The DNA was isolated from these toe 
clips and both the rGlut-1 and rC-Jun PCR assays were 
performed on the DNA as outlined in the Materials and Methods 
section. Based on the results of the genotyping, 4 fa/fa and 
9 [fa/+ or +/ + ] pups were selected for analysis of 
hypothalamic NPY expression. (See Table 7). 
Table 7: Genotype and phenotype results for 6- 
day-old F2 rat pups of the 13MxBN cross using rat 
chromosome 5 SSR polymorphisms for Glut-1 and C- 









13M/13M 13M/13M fa/fa 
BN/13M BN/13M j fa/+ 
BN/BN BN/BN + / + Lean 
BN = + allele 
13M = fa allele 
* RNA isolation of 7 of the original 24 rat pups was 
unsuccessful. Of the remaining 17 animals, 4 animals could 
not be unambiguously genotyped at the fa locus. Thus, 11 
of 24 animals were excluded from this table, and from 
further statistical analysis. 

The rat pups were sacrificed on the sixth day of life, 
and the hypothalami were harvested. Total hypothalamic mRNA 
was isolated, reverse transcribed, and assayed for NPY and 
actin mRNA by a PCR outlined in the Materials and Methods 
section. The results of the first assay, performed once on 
each sample, suggested only a minor increase in the NPY 
levels of the preobese rat pups, 1.09 vs. 1.00. The assay 
was repeated to further clarify these results, and triplicate 
measures were performed on each sample. (See Table 8). 
The singlet and triplicate hypothalamic NPY/actin mRNA 
values were compared with one another, by normalizing each 
sample value to the control NPY/actin mRNA value obtained for 
the corresponding RT-PCR assay run. Inter-assay variability 
in efficiency of the RT and PCR steps occurs, and 
autoradiogram exposure time also differs. To account for 
such variability, hypothalamic measures must be expressed 
relative to a standardized control. Thus, during each run of 
the RT-PCR assay, the same whole rat brain RNA control was 
used. It is assumed that this control always has the same 
initial concentration of NPY and actin mRNA, and that the 
resulting NPY/actin mRNA level reflects assay efficiency and 
autoradiogram exposure time. Each sample was expressed as a 
fraction of the control value obtained for that particular 
assay run, thereby allowing inter-assay comparisons. 
This group of rat pups had four separate measures of NPY 
and actin mRNA performed on each hypothalamic sample. The 
results indicate that the medians of the preobese and entire 
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lean group are identical (1.00 and 1.00) and that there is no 
statistically significant, (p >.05), difference between the 
lean and obese groups. The fa/ + group has a slightly higher 
mean of 1.20, but the values for this group are not 
statistically significantly different from the preobese 
group. However, the fa/+ group values are significantly 
higher than the +/+ group, (one-sided significance level p = 
.032). (See Table 8 and Figures 7 and 8). The comparison of 
singlet to triplicate measures shows that despite the 
variability in repeated measures on the same sample, a single 
determination of each sample is fairly reliable. 

Table 8: Triplicate and singlet hypothalamic NPY mRNA* 
determinations of 6-day-old F2 rat pups of the 13M>:BN 










3 Level Median j groups 
+/+ 0.64 0.68 0.79 
+/+ 0.71 0.90 0.96 
+/+ „ 0.88 0-89 . 1.00 
+ / + 0.86 1.01 1.10 
+/+ 0.76 1.52 1.54 
0.93 
1.27 1.40 j 
M/+.i 
T 
. 83 -IrQO-J 
1•07 1.10 ] 1.20 
1.33 ! 1.30 I 
fa/ + 1.03 2.53 
fa/fa 0.38 0.55 0.98 0.83 0.70 
fa/fa 0.80 0.84 1.23 0.87 | 1.00 
— —| 
2.27 
* NPY mRNA levels normalized to actin mRNA of the same sample. 
All triplicate values are then normalized to the whole rat brain 
control NPY/actin mRNA value for that particular assay run, and 
all singlet values are normalized to the rat brain control value 
for that assay run. All values are then normalized to the median 
of the lean group. 
The results indicate that the medians of the preobese and entire 
lean group are identical (1.00 and 1.00) and that there is no 
statistically significant, p>.05, difference between the lean and 
obese groups. The fa/+ group has a slightly higher mean of 1.20, 
but the values for this group are not statistically significantly 
different from the preobese group. However, the fa/+ group values 
are significantly higher than the +/+ group, (one-sided 
significance level p=.032). 
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Figure 7: Triplicate and Singlet Hypothalamic NPY 
Levels in 6-Day-Old Lean and Preobese 13MxBN Rat 











* Rat pups were genotyped using rat chromosome 5 SSR 
polymorphisms for Glut-1 and C-Jun in PCR linkage assays to 
the fa locus. Triplicate and singlet hypothalamic NPY mRNA 
levels were determined using the RT-PCR technique. NPY mRNA 
levels were normalized to actin mRNA of the same sample. All 
triplicate values were then normalized to the whole rat brain 
control NPY/actin mRNA value for that particular assay run, and 
all singlet values were normalized to the rat brain control value 
for the singlet assay run. All values are expressed by 
normalization to the median of the entire lean group. Triplicate 
and singlet values are shown, bars represent medians. The 
results indicate that the medians of the fa/fa and entire lean 
group are identical (1.00 and 1.00) and that there is no 
statistically significant, (p>.05), difference between the lean and 
preobese groups. The fa/+ group has a slightly higher mean of 
1.20, but the values for this group are not significantly different 
from the preobese group, (p>.05). However, the fa/+ group 
values are significantly higher than the +/+ group, (one-sided 
significance level p=.032). 
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Figure 8: RT-PCR Medians of Triplicate and Singlet 
Hypothalamic NPY Levels in 6-Day-Old Lean and 
Preobese 13MxBN Rat Pups: No Difference Between 











* Rat pups were genotyped using rat chromosome 5 SSR 
polymorphisms for Glut-1 and C-Jun in PCR linkage assays to the 
fa locus. Triplicate and singlet hypothalamic NPY mRNA levels 
were determined using the RT-PCR technique, medians are shown 
here. NPY mRNA levels were normalized to actin mRNA of the 
same sample. All triplicate values were then normalized to the 
whole rat brain control NPY/actin mRNA value for that particular 
assay run, and all singlet values were normalized to the rat brain 
control value for the singlet assay run. All values are expressed 
by normalization to the median of the entire lean group. Medians 
of the 4 measures for each animal are shown, with bars 
representing the medians of each group of animals. Medians of the 
preobese and entire lean group are identical (1.00 and 1.00) and 
there is no statistically significant, (p>.05), difference between 
the lean and preobese groups. The fa/+ group has a slightly 
higher mean of 1.20, but this is not significantly different from 
the fa/fa group, (p>.05). However, the fa/+ group values are 
significantly higher than the +/+ group, (one-sided significance 
level p=.032). 

Comparison of RT-PCR and Northern Blot Methods: 
The results of the RT-PCR method, which showed no 
difference between the NPY mRNA levels of preobese and lean 
13MxBN F2 rat pups, conflict with that of a recent RNase 
protection assay study which detected a 50% elevation of NPY 
levels in 13MxBN rat pups of the same age.16 To resolve these 
differing results, the RT-PCR and Northern blot methods were 
compared on a similar group of 13MxBN F2 rat pups. Three 
litters of rat pups (a total of 29 pups) were sacrificed on 
the 7th or 8th day of life. Spleens were harvested and DNA 
isolated for genotype analysis using the rGlut-1 and rC-Jun 
assays. Two animals with ambiguous genotypes were discarded. 
The assigned genotypes at fatty in the remaining 27 animals 
approximated the expected Mendelian distribution of an 
autosomal recessive phenotype: 8 (30%) were preobese (fa/fa) 
and 19 (70%) were lean (fa/+ or +/+). (See Table 9). 

Table 9: Genotype and phenotype determination 
of 7-8 day old F2 rat pups of the 13MxBN cross: 









13M/13M 13M/13M fa/fa 8 Preobese 
BN/13M BN/13M fa/ + 10 Lean 
BN/BN BN/BN + / + 5 Lean 
BN/BN BN/13M 
fa/+ 
or +/ + 2 Lean 
BN/13M BN/BN 
fa/+ 
or +/ + 2 Lean 
BN = + allele 
13M = fa allele 
* Two animals that scored 13M/13M by only one assay 
were not included in this table or further analysis. 
The assigned genotypes at fatty in the remaining 27 
animals approximated the expected Mendelian 
distribution of an autosomal recessive phenotype: 8 
(30%) were preobese (fa/fa) and 19 (70%) were lean 
(fa/+ or +/+) 
Rat pup hypothalami were harvested on the day of 
sacrifice for NPY mRNA analysis by the Northern blot method. 
Total hypothalamic mRNA was isolated and then electrophoresed 
through agarose gels and blotted with both NPY and actin 
probes as outlined in the Materials and Methods section. The 
results of the Northern blot show a statistically 
significant, (p < .021), increase in NPY mRNA of 37% in the 
preobese group (median 1.37) when compared to the lean group 
(median 1.00). Further statistical analysis suggests that 
this effect may only be significant when lean homozygote 

( + / + ) animals are considered in relation to their preobese 
counterparts. A comparison of the 5 +/+ animals to the 8 
fa/fa animals shows a statistically significant elevation of 
NPY in the obese group, (p < .040), the median of the fa/fa 
group is 1.40 times that of the +/+ group. Comparison of 10 
heterozygote (fa/+) lean animals to the 8 preobese (fa/fa) 
animals shows a median of 1.00 for the lean group and 1.30 
for the preobese group, but this difference is not 
significant (p >.050) . (See Table 10 and 
Figure 9). Note that not all of the lean animals could be 
unambiguously classified as either +/+ or fa/+, thus not all 
of the animals could be included in this subset analysis. 
The exclusion of these 4 animals in the comparison between 
genotype classes may have decreased the power of the subset 
analysis. 

Table 10: Northern blot determination of 
hypothalamic NPY mRNA levels for 7-8 day old lean 
and preobese F2 rat pups of the 13MxBN cross: 
elevation in the preobese group 
* NPY mRNA levels normalized to actin mRNA of the same 
sample. NPY/Actin levels are normalized to the median of 
the lean group 
fa=13M allele 
+=BN allele 
The results show a statistically significant, p<.021, 
increase in NPY mRNA of 37% in the preobese group (median 
1.37) when compared to the lean group (median 1.00) . 
Further statistical analysis suggests that this effect may 
only be significant when lean homozygote (+/+) animals are 
considered in relation to their preobese counterparts. A 
comparison of the 5 +/+ animals to the 8 fa/fa animals shows 
a statistically significant elevation of NPY in the obese 
group, p<.040, the median of the fa/fa group is 1.40 times 
that of the +/+ group. Comparison of 10 heterozygote (fa/+) 
lean animals to the 8 preobese (fa/fa) animals shows a 
median of 1.00 for the lean group and 1.30 for the preobese 
group, but this difference is not statistically significant 















Figure 9: Northern Blot Determination of 
Hypothalamic NPY mRNA Levels for 7-8 Day Old 
Lean and Preobese F2 Rat Pups of the 13MxBN 
Cross: Elevation in the Preobese Group* 
Rat Pup Genotype 
* Rat pups were genotyped using rat chromosome 5 SSR 
polymorphisms for Glut-1 and C-Jun in PCR linkage assays to the 
fa locus. Single NPY mRNA determinations were performed on 
each hypothalamic sample using the Northern blot technique. NPY 
mRNA levels were normalized to actin mRNA of the same sample. 
NPY/Actin levels were expressed by normalization to the median 
of the lean group. Bars represent the medians of each group. The 
results show a statistically significant, p<.021, increase in NPY 
mRNA of 37% in the preobese group (median 1.37) when 
compared to the lean group (median 1.00). Further statistical 
analysis suggests that this effect may only be significant when lean 
homozygote (+/+) animals are considered in relation to their 
preobese counterparts. A comparison of the 5 +/+ animals to the 
8 fa/fa animals shows a statistically significant elevation of NPY 
in the obese group, p<.040, the median of the fa/fa group is 1.40 
times that of the +/+ group. Comparison of 10 heterozygote 
(fa/+) lean animals to the 8 preobese (fa/fa) animals shows a 
median of 1.00 for the lean group and 1.30 for the preobese 
group, but this difference is not statistically significant 
(p>.050). 

Six fa/fa and 9 lean [fa/+ or 
4 5 
+ / + ] animals were selected 
for RT-PCR analysis. A portion of the hypothalamic mRNA 
sample from these animals was reverse transcribed and assayed 
for NPY and actin mRNA by the PCR as outlined in the 
Materials and Methods section. Single measures were 
performed on each sample. The results indicate that the 
medians are virtually identical, 1.00 for the entire lean 
group and 1.04 for the obese group, and that there is no 
statistically significant difference between the two groups, 
(p >.05). However, the values obtained by the Northern blot 
method for these same samples show that the median of the 
obese group is 1.41, while that of the lean group is only 
1.00. Further, the increased expression of NPY in the obese 
group, shown by the Northern blot method, is statistically 
significant, (p <.025). (See Table 11 and Figures 10 & 11). 

Table 11: Hypothalamic NPY mRNA levels for 7-8 day old 
F2 lean and preobese rat pups of the 13MxBN cross: RT- 
PCR shows no difference, while Northern blot shows 





NPY/Act in * 
Median & 






fa/fa preobese 6 1.04 1 .41 
(0.75-1.91) (0.84-1.94) 




fa/ + lean 4 " x l6 0.89 
or +/ + (0.86-1.53) (0.77-1.03) 
* NPY mRNA levels normalized to actin mRNA of the same sample, and 
these values are then normalized to the median of the lean group 
for each method. 
The medians for the RT-PCR method are virtually identical, 1.00 
for the entire lean group and 1.04 for the obese group, and there 
is no statistically significant difference between the two groups, 
p>.05. However, the values obtained by the Northern blot method 
show that the median of the obese group is 1.41, while that of the 




Figure 10: RT-PCR Determination of Hypothalamic 
mRNA Levels of 7-8 Day Old Lean and Preobese F2 
Rat Pups of the 13MxBN Cross: No Difference 










Rat Pup Genotype 
* Rat pups were genotyped using rat chromosome 5 SSR 
polymorphisms for Glut-1 and C-Jun in PCR linkage assays to the 
fa locus. Single NPY mRNA determinations were performed on 
each hypothalamic sample using the RT-PCR technique. NPY 
mRNA levels are normalized to actin mRNA of the same sample. 
NPY/actin levels are expressed by normalization to the median of 
the lean group. Bars represent medians for each group. The 
medians are virtually identical, 1.00 for the entire lean group and 
1.04 for the obese group, and there is no statistically significant 
difference between the two groups, p>.05. 

Figure 11: Northern Blot Determination of 
Ffypothalamic mRNA Levels of 7-8 Day Old Lean and 
Preobese F2 Rat Pups of the 13MxBN Cross: 











Rat Pup Genotype 
* Rat pups were genotyped using rat chromosome 5 SSR 
polymorphisms for Glut-1 and C-Jun in PCR linkage assays to the 
fa locus. Single NPY mRNA determinations were performed on 
each hypothalamic sample using the Northern blot technique. NPY 
mRNA levels were normalized to actin mRNA of the same sample. 
NPY/actin levels were expressed by normalization to the median 
of the lean group. Bars represent medians for each group. Results 
show that the median of the obese group is 1.41, while that of the 





HyPothalamic NPY Elevation in Obese Zuckers by Age: 
It has been demonstrated by several techniques that 
obese adult Zucker rats, of various ages, have elevated 
hypothalamic NPY levels. For example, a radioimmunoassay 
(RIA) technique has shown increased hypothalamic NPY peptide 
levels in 6-month-old obese Zucker rats in comparison to lean 
littermates.3 A ribonuclease (RNase) protection assay has 
shown elevations of preproNPY (ppNPY) mRNA in obese Zucker 
rats at 15 and approximately 45 weeks of age, when compared 
to lean controls. These results were also confirmed using a 
Northern blot technique in a similar group of 45-week-old 
rats . 48 
Developmental studies have yielded conflicting results 
upon examination of younger Zucker rats. One study, using a 
RNase protection assay, demonstrated elevations of ppNPY mRNA 
in obese Zucker rats at 5, 14, and 33 weeks of age. Although 
elevations were found in these obese animals at each age, the 
difference found in the older rats was greater than that 
found in the 5-week-old group.47 However, another 
developmental study, using the Northern blot technique, 
demonstrated increased NPY levels in obese fa/fa rats at 24 
and 40 weeks of age, but no difference in expression between 
younger 11-week-old lean and obese rats.29 At this same age 
of 11 weeks, another study, using an RT-PCR method, detected 
a 4-fold increase in NPY mRNA in the obese Zucker rat group.2 
The results of the present research also demonstrate an 

approximate 50% increase in hypothalamic NPY mRNA, using a 
RT-PCR technique, in 11-week-old obese F2 13M/13M animals 
from the BNxl3M cross. The discrepancies between these 
developmental studies may be partially accounted for by 
variations in hypothalamic NPY levels in younger rats, and by 
differences in NPY expression between the Zucker rat strain 
and rats of the BNxl3M cross. 
To determine the importance of elevated hypothalamic NPY 
in the production of the obese phenotype, the developmental 
analysis must be extended to the first week of life, an age 
at which other confounding phenotypic abnormalities of 
obesity are not yet present. A preliminary study using a RT- 
PCR technique failed to demonstrate differences in 
hypothalamic NPY mRNA levels between lean and preobese 13- 
day-old Zucker rat pups.2 On the other hand, a study of six- 
to-nine day old rat pups of the BNxl3M cross, using a RNase 
protection assay technique, demonstrated a 50% elevation of 
hypothalamic ppNPY in the preobese group when compared to 
heterozygous lean animals.16 The present research also yields 
differing results, depending on the technique used. The 
newer RT-PCR method detects no difference between lean and 
preobese rat pups aged 6-to-8 days old. However, the 
Northern blot technique demonstrates a statistically 
significant 37% elevation of hypothalamic 
preobese 7-to-8 day old pups. 
NPY levels in 

Acceptance of Northern Blot Results: 
A thorough consideration of the two techniques used in 
this research suggests that more confidence may be placed in 
the results obtained by the Northern blot. First, the 
Northern blot technique has been extensively used to 
determine NPY mRNA in adult rodents,15'29'48 and the results 
obtained have been reproducible by other techniques, 
including radioimmunoassay and RNase protection assay.3'4'9'46- 
48 Only one preliminary study using an RT-PCR technique to 
detect NPY mRNA has been performed,2 and the results are not 
entirely consistent with results obtained in similar studies 
using other techniques.16'29'47 Second, the results obtained 
using the Northern blot method in this study are consistent 
with those found in a recent study using another standard 
technique, the RNase protection assay.16 Only RT-PCR methods, 
used to detect NPY mRNA in this research, and in a 
preliminary report by another laboratory,2 have failed to 
detect any differences in NPY expression between lean and 
preobese pups. Third, there is more possibility for error in 
measurements performed with amplification of target 
molecules. The RT-PCR method amplifies the signal for each 
target RNA molecule between 104 — 106 fold, whereas the Northern 
blot and RNAase protection assays determine RNA levels on a 
molar basis (one molecule of probe detects one molecule of 
target RNA) . Lastly, the differences in NPY expression 
between the two groups are relatively small, and it may be 
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that the RT-PCR method is not sufficiently sensitive to 
reliably detect variations of 50% or less. 
The inability of the RT-PCR method to detect small 
differences in product amount may be secondary to determining 
a visual, rather than a mathematical standardization curve1-3 
for the oligonucleotide primer amplifications. To establish 
a standardization curve for this research, sequential PCR 
amplifications were performed, and the cycle number (ie. 20) 
at which the NPY and actin products appeared to be still 
increasingly linearly, before reaching a plateau phase, was 
determined and subsequently used. Because of differential 
primer amplification, this visual standardization curve may 
not have been accurate enough to identify relatively small, 
but significant differences in NPY expression. Furthermore, 
actin may not have been the most appropriate control product 
to generate, because it is present in much greater amounts 
than NPY. This fact necessitated the use of much longer 
autoradiogram exposure times to ascertain NPY levels (ie. 
typical exposure time for NPY was > 72 hours, while for actin 
it was < 24 hours). Even at very short exposure times, actin 
densitometry values may have already been within saturation 
range. In addition, on the longer exposures for NPY, high 
background levels of radiation may have yielded inaccurate 
NPY densitometry values. 
The above arguments support the validity of the Northern 
blot results, which demonstrate a 37% elevation of NPY in the 
preobese rat pups. Similar results obtained by a RNase 

protection assay study demonstrate a greater degree of NPY 
elevation in the preobese group, of 50%.16 This slight 
discrepancy may be accounted for by the use of only 
homozygous lean animals in that study,16 whereas both 
homozygous and heterozygous lean animals were used in the 
Northern blot study. It is possible that there is an allelic 
effect of the fatty mutation such that heterozygous animals 
have intermediate levels of hypothalamic NPY. Of additional 
note, the demonstrated degree of elevation in the preobese 
pups in both of these studies is less than that observed in 
older obese rats . 3/29,47, 48 one possible explanation for this 
finding may be that although the pups within a litter are of 
the same gestational age, the pups may differ in 
developmental maturity, such that the margin of difference in 
hypothalamic NPY expression between lean and preobese pups 
may be narrower than that found later in life. 
Strain Considerations: 
The ramifications of using the 13MxBN cross, which is 
not genetically identical to the Zucker rat strain, should be 
considered. The 13M allele from the Zucker rat strain was 
introduced into the BN rat strain. Thus, variability in NPY 
expression may be secondary to differences between the 13M 
and BN strains, rather than due to the fa mutation itself. 
To ascertain whether early hypothalamic NPY expression is 
influenced by strain differences in rodent obesity models, it 
will be necessary to evaluate hypothalamic NPY expression in 
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a single strain model, (ie., a Kaliss mouse strain: 
C57BL/KsJ) , which can be phenotyped at a very early age. 
Another implication of using two strain backgrounds is 
genetic dissimilarity between fa/fa animals. All progeny of 
13MxBN FI animals have Mendelian segregation of 13M and BN 
alleles at all loci not linked to the fa gene. In addition, 
recombinations may occur, such that in any given fa/fa 
animal, 5-10% of its genes may be heterozygous. Therefore, 
variability in the expression of the obese phenotype will 
occur if it is influenced by other polygenes, which is 
likely, since the fa/fa rats are not genetically identical 
(13M/13M) at other loci in the genome. 
Possible Role of NPY in the Development of Obesity: 
The Northern blot demonstration of the early onset of 
hypothalamic NPY elevation in preobese rat pups is 
significant because centrally acting NPY can produce 
metabolic aberrations which likely play a central role in the 
development of the obese fatty phenotype. One significant 
consequence of central NPY action is pancreatic release of 
the anabolic hormone insulin,39 which facilitates deposition 
of glucose as adipose tissue. Hyperinsulinemia is evident in 
the Zucker rats by 3 weeks of age;58 in the diabetes mouse, 
the homologue of the fatty rat, hyperinsulinemia has been 
detected as early as 10 days of age.18 Although increased 
hypothalamic NPY expression is evident prior to the onset of 




in preobese Zucker rats is enhanced in vitro 
secretion in response to acetylcholine perfusion, at 5 days 
of age.1 One possible theory regarding the mechanism of 
obesity in db mice,18 which can be generalized to fatty rats, 
suggests that hyperinsulinemia in preobese rodent pups causes 
a mild hypoglycemia, followed by a compensatory hyperphagia 
to return blood glucose levels to near normal, which in turn 
results in enhanced insulin secretion and fat deposition.18 
It may be that heightened hypothalamic NPY expression 
initiates this entire process culminating in obesity. 
Another metabolic consequence of centrally acting NPY is 
improved energy efficiency. Intracerebroventricular NPY 
administration in rats produces a hypometabolic condition by 
eliciting decreases in heart rate, respiratory rate, and mean 
arterial blood pressure. However, these effects do not occur 
if food is concomitantly consumed, presumably because 
addition of an energy source obviates the need for conserving 
energy expenditure.28 NPY also lowers body temperature,20 
leading to an overall state of decreased activity resembling 
hibernation. Not surprisingly, conditions in which energy 
conservation is required for survival, such as fasting and 
cold exposure, have been shown to elicit elevations of 
hypothalamic NPY, presumably initiating these energy 
conserving mechanisms.15'24 Given the increased hypothalamic 
NPY levels of fa/fa rats, these same mechanisms presumably 
operate, likely facilitating the increased energy storage in 
these animals. 

NPY in Humans: 
5 6 
Hypothalamic 
Central NPY has been assayed in the cerebrospinal fluid 
(CSF) of human beings with eating disorders.32 In anorexia 
nervosa patients, NPY levels were found to be elevated during 
periods of starvation, and were normalized after long-term 
weight restoration accompanied by regular eating habits.32 
These results are consistent with the relative NPY elevations 
found in rodents during periods of food deprivation, in 
comparison to those obtained after refeeding.4'9'15'29'46'48 
Bulimic patients also had significantly increased amounts of 
peptide YY (closely related to NPY) during episodes of 
abstinence from bingeing, compared to their levels during 
actively bingeing periods.32 These results suggest that 
bulimics have abnormally high levels of peptide YY which may 
be the stimulus for them to engage in periods of gross 
hyperphagia. Although hypothalamic NPY cannot be assayed 
directly in human beings, the above findings suggest that 
determination of CSF levels may be an accurate reflection of 
hypothalamic NPY production, and that CSF NPY may be elevated 
in obese patients. Thus, studies assessing central NPY 
levels in obese humans should be performed to determine if 




NPY Antagonists : 
Given that excess hypothalamic NPY can produce 
obesity,50 it is important to identify any agent capable of 
counteracting the effects of this potent neurotransmitter. 
The serotonergic drug fenfluramine is a clinically prescribed 
anorectic which has been shown to cause rapid and dramatic 
decreases in hypothalamic NPY levels in rats treated with the 
drug, suggesting that fenfluramine mediates its appetite- 
suppressant effects by inhibition of hypothalamic NPY 
activity.45 However, fenfluramine is characterized by 
significant side effects, and appears unable to sustain long¬ 
term weight reduction.25 
Recently the cobalt substituted heme compound, cobalt- 
protoporphyrin (CoPP), was shown to dramatically reduce both 
food intake, and weight in rats (including obese fatty rats), 
mice, chickens, and dogs when injected either peripherally, 
i n t r a c e r e b r o v e n t r i c u 1 a r 1 y , 2 ^ or directly into the 
hypothalamus.22 CoPP causes an initial 2-3 day period of 
hypophagia coupled with marked weight reduction, followed by 
resumption of normal food intake levels, and a gradual return 
to normal body weight 200-300 days after CoPP injection. 
This dramatic weight loss persists long after food intake has 
returned to normal, suggesting a CoPP-mediated aberration of 
body fat metabolism.23 
Investigations suggest that CoPP produces weight loss by 
interfering with hypothalamic NPY action. Hypophagic CoPP- 
treated rats were shown to have an appropriate increase in 

hypothalamic NPY mRNA, but this was not translated into the 
expected corollary of food ingestion.22 
I ntracerebroventricular NPY administration to CoPP-treated 
rats also did not increase food intake as anticipated.22 
Since CoPP did not block the production of hypothalamic NPY, 
and exogenous NPY did not induce feeding, additional studies 
have focused on the first site of NPY action, its 
hypothalamic receptor. These studies, performed in rats, 
have demonstrated that CoPP treatment does not alter either 
the number of NPY receptors, or their affinity for NPY. 
Thus, the mechanism of action of CoPP must be distal to the 
NPY receptor(Michael Turner-personal communication). Further 
explorations into CoPP, and other antagonists28' 55 of the 
orexigenic effect of NPY may eventually lead to a viable 
pharmacologic agent for the treatment of hypothalamic NPY- 
mediated obesity. 
Conclusion: 
Human obesity is considered to have both behavioral and 
genetic components. The Zucker rat provides a valuable model 
of an inherited obesity syndrome caused by an unidentified 
autosomal recessive mutation of the fatty (fa) gene on 
chromosome 5. The development of obesity in animal models 
appears to be influenced by hypothalamic neuropeptide Y 
(NPY) , via metabolic aberrations inducing hyperphagia, 
hyperinsulinemia, and energy conservation mechanisms. 
Elevated hypothalamic NPY levels have been consistently 

demonstrated in obese adult Zucker rats in comparison to lean 
Zucker rats.3'29'47''58 However, until recently, it has not 
been possible to assess the causal role of NPY in the 
development of this obesity, because the genotype of Zucker 
rat pups could not be determined prior to the onset of 
visible obesity. The creation of a new rat cross (13MxBN), 
similar to the Zucker rat strain (13M/13M), and 
identification of polymorphic genetic markers flanking the fa 
locus has permitted genotyping of 13MxBN rats at any age. 
The purpose of the present study was to elucidate the 
potential role of hypothalamic NPY in the development of the 
obese phenotype of the fatty rat, by comparing hypothalamic 
NPY levels in lean and preobese 13MxBN rat pups, using the 
RT-PCR and Northern blot methods. The RT-PCR technique, 
which requires amplification of target sequence, showed no 
statistically significant difference between 6-8 day-old lean 
and preobese pups. However, the Northern blot method, which 
detects native mRNA, demonstrated a significant elevation of 
-40%, (p<.021), in preobese rat pups at 7-8 days of age, 
compared to their lean littermates. Furthermore, the 
Northern blot results are consistent with those recently 
obtained with an RNAase protection assay.16 These studies 
provide evidence that elevated hypothalamic NPY is one of the 
earliest known molecular abnormalities in a genetic animal 
model of obesity, and suggest that NPY is integrally involved 
in producing the obese phenotype. Studies of central NPY 
expression in human beings with eating disorders suggest that 
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the NPY elevations in obese rodents may be relevant to obese 
humans, and imply that investigations into hypothalamic NPY 
antagonists may eventually lead to a pharmacolgic agent for 
the treatment of obesity. 
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